Evolution of Continuous Process in Upstream and its Competition with Fed Batch Platform
Posted on September 7, 2017
Ankur Bhatnagar, Chief Scientific Manager, Cell Culture Lab* * Cell Culture lab (CCL) – The CCL is the upstream process development group at Biocon Research limited which focusses on developing, characterizing and scaling up processes using Mammalian cells. The group has developed and scaled-up many Fed batch and Perfusion based processes both for Biosimilar and Novel Biologics.
Dinesh Baskar, Senior Scientific Manager, Cell Culture Lab*
Saravanan Desan, Scientific Manager, Cell Culture Lab*
Mandeep Kaur, Principal Scientist, Cell Culture Lab*
Janani K, Associate Scientific Manager, Cell Culture Lab*
Chandrashekhar K.N., Associate Scientific Manager, Cell Culture Lab*
Biocon Research Limited
Abdul Waheed, Assistant Manager, Manufacturing Support (MSAT)
Biocon Limited
Continuous processing is the new buzz word in town these days during any discussion on future process technology in the biotechnology industry. Many suppliers of the equipment – big or small – seems to be coming up with some form of product that supports continuous processing both in upstream an...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
Ankur, Biocon R&D, Cell culture media, cell culture medium, cell lines, cell retention devices, Continuous Processing, culture processes, downstream, fed-batch process, multi-product facilities, process technology, unit operations, upstream
Related Products
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
